Clinical trial to evaluate the safety, tolerability and effectiveness of a medicinal nasal insert in the treatment of chronic hay fever.- Inspicare
This research study, called Inspicare, is looking for people who suffer from chronic hay fever, also known as ongoing allergic rhinitis. Researchers want to test a new type of medicine that comes in a small device worn inside the nose. This is a very early stage trial, meaning it's the first time this specific treatment is being given to people. The main goals are to check if the nasal insert is safe to use, if people can easily tolerate it, and if it might help with hay fever symptoms. Finding new ways to manage hay fever could improve many people's quality of life, especially for those whose symptoms regularly disrupt their daily activities.
At a glance
What is this study about?
This study is all about helping people who have ongoing hay fever, which doctors often call chronic allergic rhinitis. If you have chronic hay fever, you'll know all about the sneezing, runny nose, itchy eyes, and blocked-up feelings that can happen regularly, not just for a short time each year. This clinical trial, named Inspicare, is exploring a completely new way to deliver medicine directly into your nose using a small insert.
The main purpose of this particular study is to see if this new nasal insert is safe for people to use. Because it's the first time this specific device and medicine combination is being tested in humans, the medical team will be very carefully checking for any side effects and how well people get on with wearing the insert. They also want to understand if it's comfortable and easy to use, and to get an early idea of whether it could be helpful for hay fever symptoms.
Finding better ways to treat chronic hay fever is important because for many people, current treatments don't always fully control their symptoms, or they might have side effects. A new, easy-to-use treatment could make a big difference to how people manage their hay fever and improve their daily lives.
Key takeaways
- This study is testing a new nasal insert for chronic hay fever.
- It's a very early-stage trial, focusing on safety and how well people tolerate the treatment.
- Adults 18 and over, both men and women, with chronic hay fever can take part.
- Participation involves clinic visits, medical checks, and using the nasal insert.
- There are potential benefits like early access to new treatment, but also unknown risks.
- You can stop participating at any time if you change your mind.
Who may be eligible?
To join this study, you need to be an adult, which means you must be 18 years old or older. There is no upper age limit, so people of all adult ages can take part.
Both men and women are welcome to participate in this study. The researchers are looking to include a diverse group of people to make sure the results apply to everyone.
Specifically, you must have been diagnosed with chronic allergic rhinitis, which is ongoing hay fever. The researchers will check your medical history and current health to make sure this study is right for you and that you meet all the necessary health requirements.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Do you suffer from ongoing hay fever (chronic allergic rhinitis)?
- Are you able to attend regular clinic appointments?
- Are you willing to use a new type of treatment in your nose?
- Are you comfortable with doctors closely monitoring your health?
What does participation involve?
If you join this study, you'll be part of the first group of people to try this new treatment. This means there will be several visits to the study clinic where doctors and nurses will closely monitor your health. You'll likely have medical check-ups, some blood tests, and probably answer questionnaires about your hay fever symptoms and how you're feeling. They will teach you how to use the nasal insert. You'll use the medicine as instructed, and the team will regularly check how your body is reacting to it. The visits will continue for a certain period, and there will be follow-up appointments even after you stop using the device to make sure you're doing well.
Potential risks and benefits
Locations (1)
- —UnverifiedNetherlands
Common questions
What is chronic hay fever?
Chronic hay fever, or chronic allergic rhinitis, is when you have hay fever symptoms like sneezing, runny nose, or itchy eyes for many weeks or months, not just during pollen season. It's often triggered by things like dust mites or pet dander.
What is a nasal insert?
A nasal insert is a small device that goes inside your nose. In this study, it's designed to deliver medicine directly to help with hay fever symptoms.
What does 'Phase I' mean?
Phase I means this is the very first time this treatment is being given to people. The main goal is to check its safety and how well people tolerate it, rather than primarily how effective it is.
Will this cure my hay fever?
It's too early to say if this treatment will cure hay fever. This study is mainly focused on checking safety and tolerability. Any potential benefits for symptoms will also be observed.
Do I have to pay to join the study?
No, you do not have to pay to participate in a clinical trial. All study-related treatments and visits are typically covered by the research study.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.